US$ 20.84
semaglutide heart failure in Patients With Obesity and Across Mildly Reduced or Preserved Ejection Fraction Real-world data link semaglutide, tirzepatide
Description
Are Glucagon-Like Peptide-1 (GLP-1) receptor agonists Central Nervous System (CNS) penetrant: a narrative review

[DOI] [PubMed] [Google Scholar] 925.Clemmensen C., Finan B., Muller T.D., DiMarchi R.D., Tschop M.H., Hofmann S.M

Everybody thinks its Ozempic, but its not
01498-3/asset/1bfe2676-8fc3-4819-9b9c-2eaed52783bd/main.assets/gr2_lrg.jpg)
About the author Maia Anderson Maia Anderson is a senior reporter at Healthcare Brew, where she focuses on pharma developments like GLP-1s and psychedelic medicine, pharmacies, and women's health.
